Immunome, Inc. (IMNM)
21.84
-0.61
(-2.72%)
USD |
NASDAQ |
Apr 02, 16:00
21.95
+0.11
(+0.50%)
After-Hours: 20:00
Immunome Total Liabilities (Quarterly) : 48.84M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 114.23M |
| Scholar Rock Holding Corp. | 158.78M |
| Stoke Therapeutics, Inc. | 65.98M |
| Nurix Therapeutics, Inc. | 163.82M |
| CytomX Therapeutics, Inc. | 53.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 683.19M |
| Shareholders Equity (Quarterly) | 634.34M |
| Debt to Equity Ratio | 0.0061 |
| Current Ratio | 14.69 |
| Net Debt Paydown Yield | -0.01% |